Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-008029

Director bought 35,000 shares at $1.63 ($57,050)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Amin Dipti Director 2022-03-28 Purchase +35,000 $1.63 $57,050 35,000 D: show line 1 in the form
Open-market purchases · 35,000 sh · avg $1.63 · $57,050
Loading xslF345X03/ownership.xml…